Chemomab Therapeutics Ltd. Annual Return On Equity in % from 2019 to 2022

Taxonomy & unit
ratio: %
Description
Return on equity can be defined as the amount of net income returned as a percentage of shareholders equity. Return on equity measures a corporation's profitability by revealing how much profit a company generates with the money shareholders have invested.
Summary
Chemomab Therapeutics Ltd. quarterly/annual Return On Equity history and growth rate from 2019 to 2022.
  • Chemomab Therapeutics Ltd. Return On Equity for the quarter ending June 30, 2023 was -101 %, a 209% decline year-over-year.
  • Chemomab Therapeutics Ltd. annual Return On Equity for 2022 was -58.2 %, a 192% decline from 2021.
  • Chemomab Therapeutics Ltd. annual Return On Equity for 2021 was -20 %, a 61% increase from 2020.
  • Chemomab Therapeutics Ltd. annual Return On Equity for 2020 was -51.2 %, a 56.9% increase from 2019.
Return On Equity, Annual (%)
Return On Equity, YoY Annual Growth (%)
Period Value YoY Chg Change % Start Date End Date
2022 -58.2 -38.3 -192% Jan 1, 2022 Dec 31, 2022
2021 -20 +31.3 +61% Jan 1, 2021 Dec 31, 2021
2020 -51.2 +67.5 +56.9% Jan 1, 2020 Dec 31, 2020
2019 -119 Jan 1, 2019 Dec 31, 2019
* An asterisk sign (*) next to the value indicates that the value is likely invalid.